← SynDRA
JI-101
SynDRA canonical compound SYN0038231 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | EPHB4 | KDR | PDGFRB |
|---|
| Mechanism of action | kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EPHB4 INHIBITOR
- Ephrin type-B receptor 4 inhibitor
- PDGFRB INHIBITOR
- Platelet-derived growth factor receptor beta inhibitor
- KDR INHIBITOR
- Vascular endothelial growth factor receptor 2 inhibitor
- kinase inhibitor
- ERBB4 MODULATOR
Cross-references
Synonyms
- Angiogenesis inhibitor ji-101
- CGI-1842
- JI 101
- UNII-980M4N37DH
- 980M4N37DH
- 1-(1-((2-AMINOPYRIDIN-4-YL)METHYL)-1H-INDOL-4-YL)-3-(5-BROMO-2-METHOXYPHENYL)UREA
- SCHEMBL5585996
- CHEMBL3545155
- MolPort-044-567-620
- BCP16892
- EX-A2371
- ZINC38255464
- AKOS030526978
- SB16904
- DB12744
- CS-5636
- Urea, N-(1-((2-amino-4-pyridinyl)methyl)-1H-indol-4-yl)-N'-(5-bromo-2-methoxyphenyl)-
- KB-77988
- HY-16265
- JI101 cpd
- RefChem:150485
- JI-?101
- MFCD26142530
- C22H20BrN5O2
- orb1304166
- SCHEMBL29375077
- NSC762381
- NSC801003
- JI-101?
- NSC-762381
- NSC-801003
- AC-36045
- BS-17924
- DA-64640
- NS00072234
- T3476
- F981162
- cgi-1842
- ALB57388
Look up JI-101 in the interactive SynDRA portal →